MainBoardUpcoming
Sai Parenteral's Limited
Company websiteInvestor note: Sai Parenteral's Limited aims to raise ₹1,04,28,288 crore. The fresh issue of ₹72,70,408 crore goes to the company while the OFS of ₹31,57,880 crore is an existing-shareholder sale.
Subscription window: 24-03-2026 to 27-03-2026. Allotment and listing timelines: 30-03-2026 / 02-04-2026. Tip: check promoter holding and recent financials before applying.
Start Date24-03-2026
End Date27-03-2026
Listing Date02-04-2026
Allotment Date30-03-2026
Current Price₹0
GMP₹0 (0.00%)
Lot Size38 Shares
Subscription0 Times
Face Value₹5 per share
Listing atNSE, BSE
Issue Price₹372 - ₹392
Pre Issue₹3,69,08,823
Post Issue₹4,41,79,231
Issue Size₹1,04,28,288
(aggregating up to 408.79 Cr)
(aggregating up to 408.79 Cr)
Fresh Issue₹72,70,408
(aggregating up to 285.00 Cr)
(aggregating up to 285.00 Cr)
Offer For Sale₹31,57,880
(aggregating up to 123.79 Cr)
(aggregating up to 123.79 Cr)
The Grey Market Premium (GMP) for Sai Parenteral's Limited is currently around ₹0 (0.00%). This indicates an estimated listing price of approximately ₹372 based on the latest market sentiment. Please note that GMP values are unofficial and can change frequently as they depend on demand, market conditions, and investor activity.
Gmp Details
| Last Updated | IPO Price | GMP | Estimated Listing Price |
|---|---|---|---|
17 Mar 2026, 07:32 | ₹392 | ₹0 | ₹392 (0.00%) |
Financials overview In Crores
Here is a quick look at the recent financial performance of Sai Parenteral's Limited . The numbers below ( In Crores ) show how the company’s revenue and profits have changed over the last few years. This helps investors understand how strongly the business is growing and how stable its financial health is before applying for the IPO.
Key Performance
| KPI | Sep-25 | Mar-25 | Mar-24 |
|---|---|---|---|
EPS | 2.82 | 5.43 | 3.19 |
ROE | 0 | 0 | 0 |
ROCE | 9.28 | 28.92 | 20.52 |
RONW | 0 | 0 | 0 |
PRE IPO(PE) | 0 | 0 | 0 |
POST IPO(PE) | 0 | 0 | 0 |
The IPO reservation for Sai Parenteral's Limited shows how the total issue is divided among different investor categories. This includes allocations for Retail Investors, Qualified Institutional Buyers (QIBs), and Non-Institutional Investors (NIIs). Understanding the reservation structure helps investors know how much of the issue is set aside for their category before applying.
IPO Reservation
| Category | Shares Offers | No. of Shares |
|---|---|---|
QIB | 50.00% | 52,14,144 |
HNI | 15.00% | 15,64,243 |
RETAIL | 35.00% | 36,49,901 |
TOTAL | 100.00% | 1,04,28,288 |
Lot(s) Distribution
| Category | Lot(s) | Qty | Amount | Reserved |
|---|---|---|---|---|
Retail (Min) | 1 | 38 | ₹14,896 | |
sHNI | 14 | 532 | ₹2,08,544 | |
bHNI | 68 | 2,584 | ₹10,12,928 |
Below you can find the official contact details of Sai Parenteral's Limited along with the registrar handling the IPO process. This information helps investors reach out for queries related to the company or for checking the allotment status and application updates once the IPO process begins.
Company Details
Email: cs@saiparenterals.com
Phone: +91 79979 91301
Website: https://www.saiparenterals.com/
Address: Plot No 39 5th floor, Lavanya Arcade Jayabheri Enclave Gachibowli, K.V.Rangareddy, Seri Lingampally Hyderabad, Telangana, 500032